Notice of Concern: Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, and Harding JW (2012) Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers, J Pharmacol Exp Ther, 340: 539-548; DOI: https://doi.org/10.1124/jpet.111.188136
2021 ◽
Vol 378
(3)
◽
pp. 314-314
2012 ◽
Vol 18
(10 Supplement)
◽
pp. B3-B3
Leen H. Kawas
◽
Brandi C. Ward
◽
Chromewell Mojica
◽
John W. Wright
◽
Joseph W. Harding
Leen H. Kawas
◽
Phillip Harris
◽
Kevin Church
◽
John W. Wright
◽
Joseph W. Harding
2012 ◽
Vol 2
(3)
◽
pp. 298-318
◽
John W. Wright
◽
Wendy L. Wilson
◽
Vanessa Wakeling
◽
Alan S. Boydstun
◽
Audrey Jensen
◽
...
Leen Hashem Kawas
◽
Joseph W Harding
◽
John W Wright
◽
Brent Yamamoto
2011 ◽
Vol 340
(3)
◽
pp. 539-548
◽
Leen H. Kawas
◽
Alene T. McCoy
◽
Brent J. Yamamoto
◽
John W. Wright
◽
Joseph W. Harding
2010 ◽
Vol 333
(1)
◽
pp. 161-173
◽
B. J. Yamamoto
◽
P. D. Elias
◽
J. A. Masino
◽
B. D. Hudson
◽
A. T. McCoy
◽
...
2014 ◽
Vol 351
(2)
◽
pp. 390-402
◽
Caroline C. Benoist
◽
Leen H. Kawas
◽
Mingyan Zhu
◽
Katherine A. Tyson
◽
Lori Stillmaker
◽
...
2015 ◽
Vol 352
(2)
◽
pp. 379-379
Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, and Harding JW (2014) The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System, J Pharmacol Exp Ther, 351: 390-402; DOI: https://doi.org/10.1124/jpet.114.218735
2021 ◽
Vol 378
(3)
◽
pp. 311-311
1998 ◽
Vol 5
(1)
◽
pp. 122A-122A
D SOMERSET
◽
E JAUNIAUX
◽
A STRAIN
◽
S AFFORD
◽
M KILBY
Close
Export Citation Format
Close
Share Document
Close